Get the Stockscreener App
3.47
13.47%
-0.54
After Hours:
3.45
-0.02
-0.58%
Scisparc Ltd stock is traded at $3.47, with a volume of 231.86K.
It is down -13.47% in the last 24 hours and up +91.71% over the past month.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$4.01
Open:
$3.7
24h Volume:
231.86K
Relative Volume:
0.05
Market Cap:
$1.86M
Revenue:
$1.75M
Net Income/Loss:
$-5.68M
P/E Ratio:
-0.7121
EPS:
-4.8726
Net Cash Flow:
-
1W Performance:
-23.90%
1M Performance:
+91.71%
6M Performance:
+1,123%
1Y Performance:
+1,446%
1-Day Range:
$3.38
$3.76
1-Week Range:
$3.38
$4.6245
52-Week Range:
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
3.47 | 6.51M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Scisparc Ltd Stock (SPRC) Latest News
Is SciSparc Ltd. stock a top momentum play2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
Candlestick signals on SciSparc Ltd. stock todayEntry Point & Daily Oversold Bounce Ideas - newser.com
Is SciSparc Ltd. stock entering bullish territoryShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Will SciSparc Ltd. price bounce be sustainableSell Signal & Stock Market Timing Techniques - newser.com
How SciSparc Ltd. stock compares to market leadersJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Why SciSparc Ltd. stock remains on buy lists2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Price momentum metrics for SciSparc Ltd. explained2025 Major Catalysts & Daily Stock Trend Reports - newser.com
How to forecast SciSparc Ltd. trends using time seriesDip Buying & Long-Term Capital Growth Strategies - newser.com
SciSparc And AutoMax Call Off Merger - Sahm
SciSparc and AutoMax Motors terminate merger agreement By Investing.com - Investing.com Australia
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors - GlobeNewswire
SciSparc Ltd. cancelled the acquisition of remaining stake in Automax Motors Ltd. - MarketScreener
What candlestick patterns are forming on SciSparc Ltd.July 2025 Volume & Smart Investment Allocation Insights - newser.com
SciSparc Ltd. Terminates Merger Agreement with AutoMax Motors - TipRanks
SciSparc, AutoMax Motors mutually agree to terminate merger - TipRanks
Scisparc Ltd. announces framework agreement regarding merger with AutoMax Motors - MarketScreener
SciSparc Ltd. and AutoMax Motors Ltd. Announce Mutual Termination of Merger and Loan Repayment Agreement - Quiver Quantitative
SciSparc and AutoMax Motors terminate merger agreement - Investing.com
$4.25M Repayment Plan: SciSparc & AutoMax Mutually Terminate Merger; $2M in Monthly Repayments - Stock Titan
SciSparc’s MitoCareX Merger with N2OFF Approved by Shareholders - MSN
SciSparc Shareholders Approve Merger with AutoMax - MSN
Backtesting results for SciSparc Ltd. trading strategies2025 Market Overview & Capital Efficiency Focused Strategies - newser.com
SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% - MSN
SciSparc stock surges after N2OFF shareholders approve MitoCareX acquisition - Investing.com
SciSparc Surge: Analyzing Latest Developments - StocksToTrade
SciSparc Shares Surge: Time to Invest? - timothysykes.com
Morning Market Movers: SPRC, APDN, EPSM, WOLF See Big Swings - RTTNews
SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition - Nasdaq
N2OFF shareholders approve acquisition of MitoCareX Bio from SciSparc By Investing.com - Investing.com Nigeria
N2OFF shareholders approve acquisition of SciSparc subsidary - TipRanks
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
N2OFF shareholders approve acquisition of MitoCareX Bio from SciSparc - Investing.com India
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewswire
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):